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Abstract
Motivation:Drug discovery demands rapid quantificationof compound-protein interaction (CPI). However,
there is a lack of methods that can predict compound-protein affinity from sequences alone with high
applicability, accuracy, and interpretability.
Results: We present a seamless integration of domain knowledges and learning-based approaches.
Under novel representationsof structurally-annotatedprotein sequences, a semi-supervised deep learning
model that unifies recurrent and convolutional neural networks has been proposed to exploit both
unlabeled and labeled data, for jointly encoding molecular representations and predicting affinities. Our
representationsandmodels outperformconventional options in achieving relative error in IC50 within 5-fold
for test cases and 20-fold for protein classes not included for training. Performances for new protein classes
with few labeled data are further improved by transfer learning. Furthermore, separate and joint attention
mechanisms are developed and embedded to our model to add to its interpretability, as illustrated in case
studies for predicting and explaining selective drug-target interactions. Lastly, alternative representations
using protein sequences or compound graphs and a unified RNN/GCNN-CNN model using graph CNN
(GCNN) are also explored to reveal algorithmic challenges ahead.
Availability:Data and source codes are available at https://github.com/Shen-Lab/DeepAffinity
Contact: yshen@tamu.edu
Supplementary information: Supplementary data are available at
http://shen-lab.github.io/deep-affinity-bioinf18-supp-rev.pdf.
1 Introduction
Drugs are often developed to target proteins that participate in many
cellular processes. Among almost 900 FDA-approved drugs as of year
2016, over 80% are small-molecule compounds that act on proteins for
drug effects (Santos et al., 2017). Clearly, it is of critical importance
to characterize compound-protein interaction for drug discovery and
development, whether screening compound libraries for given protein
targets to achieve desired effects or testing given compounds against
possible off-target proteins to avoid undesired effects. However,
experimental characterization of every possible compound-protein pair
can be daunting, if not impossible, considering the enormous chemical
and proteomic spaces. Computational prediction of compound-protein
interaction (CPI) has therefore made much progress recently, especially
for repurposing and repositioning known drugs for previously unknown
but desired new targets (Keiser et al., 2009; Power et al., 2014) and for
anticipating compound side-effects or even toxicity due to interactions
with off-targets or other drugs (Chang et al., 2010; Mayr et al., 2016).
Structure-based methods can predict compound-protein affinity, i.e.,
how active or tight-binding a compound is to a protein; and their
results are highly interpretable. This is enabled by evaluating energy
models (Gilson and Zhou, 2007) on 3D structures of protein-compound
complexes. As these structures are often unavailable, they often need
to be first predicted by “docking" individual structures of proteins and
compounds together before their energies can be evaluated, which tends
to be a bottleneck for computational speed and accuracy (Leach et al.,
2006). Machine learning has been used to improve scoring accuracy based
on energy features (Ain et al., 2015).
More recently, deep learning has been introduced to predict compound
activity or binding-affinity from 3D structures directly. Wallach et al.
developed AtomNet, a deep convolutional neural network (CNN), for
modeling bioactivity and chemical interactions (Wallach et al., 2015).
Gomes et al. (Gomes et al., 2017) developed atomic convolutional neural
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network (ACNN) for binding affinity by generating new pooling and
convolutional layers specific to atoms. Jimenez et al. (Jimenez et al., 2018)
also used 3D CNN with molecular representation of 3D voxels assigned
to various physicochemical property channels. Besides these 3D CNN
methods, Cang and Wei represented 3D structures in novel 1D topology
invariants inmultiple channels forCNN (Cang and Wei, 2017). These deep
learningmethods often improve scoring thanks tomodeling long-range and
multi-body atomic interactions. Nevertheless, they still rely on actual 3D
structures of CPI and remain largely untested on lower-quality structures
predicted from docking, which prevents large-scale applications.
Sequence-based methods overcome the limited availability of
structural data and the costly need of molecular docking. Rather,
they exploit rich omics-scale data of protein sequences, compound
sequences (e.g. 1D binary substructure fingerprints (Wang et al., 2009))
and beyond (e.g. biological networks). However, they have been
restricted to classifying CPIs (Chen et al., 2016) mainly into two types
(binding or not) and occasionally more (e.g., binding, activating,
or inhibiting (Wang and Zeng, 2013)). And more importantly, their
interpretablity is rather limited due to high-level features. Earlier sequence-
based machine learning methods are based on shallow models for
supervised learning, such as support vector machines, logistic regression,
random forest, and shallow neural networks (Cheng et al., 2012; Yu et al.,
2012; Tabei and Yamanishi, 2013; Shi et al., 2013; Cheng et al., 2016).
These shallow models are not lack of interpretability per se, but the
sequence-based high-level features do not provide enough interpretability
for mechanistic insights on why a compound–protein pair interacts or not.
Deep learning has been introduced to improve CPI identification
from sequence data and shown to outperform shallow models. Wang
and Zeng developed a method to predict three types of CPI based on
restricted Boltzmann machines, a two-layer probabilistic graphical model
and a type of building block for deep neural networks (Wang and Zeng,
2013). Tian et al. boosted the performance of traditional shallow-
learning methods by a deep learning-based algorithm for CPI (Tian et al.,
2016). Wan et al. exploited feature embedding algorithm such as
latent semantic algorithm (Deerwester et al., 1990) and word2vec
(Mikolov et al., 2013) to automatically learn low-dimensional feature
vectors of compounds and proteins from the corresponding large-scale
unlabeled data (Wan and Zeng, 2016). Later, they trained deep learning
to predict the likelihood of their interaction by exploiting the learned
low-dimensional feature space. However, these deep-learning methods
inherit from sequence-based methods two limitations: simplified task of
predicting whether rather than how active CPIs occur as well as low
interpretability due to the lack of fine-resolution structures. In addition,
interpretability for deep learning models remains a challenge albeit with
fast progress especially in a model-agnostic setting (Ribeiro et al., 2016;
Koh and Liang, 2017) .
As has been reviewed, structure-based methods predict quantitative
levels of CPI in a realistic setting and are highly interpretable with
structural details. But their applicability is restricted by the availability
of structure data, and the molecular docking step makes the bottleneck of
their efficiency. Meanwhile, sequence-based methods often only predict
binary outcomes of CPI in a simplified setting and are less interpretable
in lack of mechanism-revealing features or representations; but they are
broadly applicable with access to large-scale omics data and generally fast
with no need of molecular docking.
Our goal is to, realistically, predict quantitative levels of CPIs
(compound-protein affinity measured in IC50,Ki, orKd) from sequence
data alone and to balance the trade-offs of previous structure- or
sequence-based methods for broad applicability, high throughput and
more interpretability. From the perspective of machine learning, this is a
much more challenging regression problem compared to the classification
problem seen in previous sequence-based methods.
To tackle the problem, we have designed interpretable yet compact
data representations and introduced a novel and interpretable deep
learning framework that takes advantage of both unlabeled and labeled
data. Specifically, we first have represented compound sequences
in the Simplified Molecular-Input Line-Entry System (SMILES)
format (Weininger, 1988) and protein sequences in novel alphabets of
structural and physicochemical properties. These representations are
much lower-dimensional and more informative compared to previously-
adopted small-molecule substructure fingerprints or protein Pfam
domains (Tian et al., 2016). We then leverage the wealth of abundant
unlabeled data to distill representations capturing long-term, nonlinear
dependencies among residues/atoms in proteins/compounds, by pre-
training bidirectional recurrent neural networks (RNNs) as part of the
seq2seq auto-encoder that findsmuch success inmodeling sequence data in
natural language processing (Kalchbrenner and Blunsom, 2013). And we
develop a novel deep learning model unifying RNNs and convolutional
neural networks (CNNs), to be trained from end to end (Wang et al.,
2016b) using labeled data for task-specific representations and predictions.
Furthermore, we introduce several attention mechanisms to interpret
predictions by isolating main contributors of molecular fragments or their
pairs, which is further exploited for predicting binding sites and origins of
binding specificity. Lastly, we explore alternative representations using
protein sequences or compound graphs (structural formulae), develop
graph CNN (GCNN) in our unified RNN/GCNN-CNNmodel, and discuss
remaining challenges.
The overall pipeline of our unified RNN-CNN method for semi-
supervised learning (data representation, unsupervised learning, and joint
supervised learning) is illustrated in Fig. 1 with details given next.
2 Materials and Methods
2.1 Data
We used molecular data from three public datasets: labeled compound-
protein binding data fromBindingDB (Liu et al., 2006), compound data in
the SMILES format from STITCH (Kuhn et al., 2007) and protein amino-
acid sequences from UniRef (Suzek et al., 2014).
From 489,280 IC50-labeled samples collected from BindingDB, we
completely excluded four classes of proteins from the training set:
nuclear estrogen receptors (ER; 3,374 samples), ion channels (14,599
samples), receptor tyrosine kinases (34,318 samples), and G-protein-
coupled receptors (GPCR; 60,238 samples), to test the generalizability of
our framework. And we randomly split the rest into the training (263,583
samples including 10% held out for validation) and the default test set
(113,168 samples) without the aforementioned four classes of protein
targets. Similarly, we split aKi (Kd) labeled dataset into 101,134 (8,778)
samples for training, 43,391 (3,811) for testing, 516 (4) for ERs, 8,101
(366) for ion channels, 3,355 (2,306) for tyrosine kinases, and 77,994
(2,554) for GPCRs. All labels are in logarithm forms: pIC50, pKi, and
pKd. More details can be found in Sec. 1.1 of Supplementary Data.
For unlabeled compounddata fromSTITCH,we randomly chose 500K
samples for training and 500K samples for validation (sizes were restricted
due to computing resources) and then removed those whose SMILES
string lengths are above 100, resulting in 499,429 samples for training and
484,481 for validation. For unlabeled protein data from UniRef, we used
all UniRef50 samples (50% sequence-identity level) less those of lengths
above 1,500, resulting in 120,000 for training and 50,525 for validation.
2.2 Input data representation
Only 1D sequence data are assumed available. 3D structures of proteins,
compounds, or their complexes are not used.
2.2.1 Compound data representation
Baseline representation. Apopular compound representation is based
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Fig. 1. The pipeline of our unified RNN-CNN method to predict and interpret compound-protein affinity.
on1Dbinary substructurefingerprints fromPubChem (Wang et al., 2009).
Mainly, basic substructures of compounds are used as fingerprints by
creating binary vectors of 881 dimensions.
SMILES representation. We used SMILES (Weininger, 1988) that
are short ASCII strings to represent compound chemical structures based
on bonds and rings between atoms. 64 symbols are used for SMILES
strings in our data. 4more special symbols are introduced for the beginning
or the end of a sequence, padding (to align sequences in the same
batch), or not-used ones. Therefore, we defined a compound “alphabet"
of 68 “letters". Compared to the baseline representation which uses k-
hot encoding, canonical SMILES strings fully and uniquely determine
chemical structures and are yet much more compact.
2.2.2 Protein data representation
Baseline representation. Previously the most common protein
representation for CPI classification was a 1D binary vector whose
dimensions correspond to thousands of (5,523 in (Tian et al., 2016)) Pfam
domains (Finn et al., 2014) (structural units) and 1’s are assigned based
on k-hot encoding (Tabei and Yamanishi, 2013; Cheng et al., 2016). We
considered all types of Pfam entries (family, domain, motif, repeat,
disorder, and coiled coil) for better coverage of structural descriptions,
which leads to 16,712 entries (Pfam 31.0) as features. Protein sequences
are queried in batches against Pfam using the web server HMMER
(hmmscan) (Finn et al., 2015) with the default gathering threshold.
Structural property sequence (SPS) representation. Although
3D structure data of proteins is often a luxury and their prediction
remains a challenge without templates, it has been of much
progress to predict protein structural properties from sequences
(Cheng et al., 2005; Magnan and Baldi, 2014; Wang et al., 2016a). We
used SSPro/ACCPro (Magnan and Baldi, 2014) to predict secondary
structure class (α-helix, β-strand, and coil) and solvent accessibility
(exposed or not) for each residue and group neighboring residues of
the same secondary structure class into secondary structure elements
(SSEs). The details and the pseudo-code for SSE are in Algorithm 1
(Supplementary Data).
Each SSE is further classified: solvent exposed if at least 30% of
residues are and buried otherwise; polar, non-polar, basic or acidic based
on the highest odds (for each type, occurrence frequency in the SSE is
normalized by background frequency seen in all protein sequences to
remove the effect from group-size difference); short if length L 6 7,
medium if 7 < L 6 15, and long if L > 15. In this way, we defined
4 separate alphabets of 3, 2, 4 and 3 letters, respectively to characterize
SSE category, solvent accessibility, physicochemical characteristics, and
length (Table S1) and combined letters from the 4 alphabets in the order
above to create 72 “words” (4-tuples) to describe SSEs. Pseudo-code for
the protein representation is shown as Algorithm 2 in Supplementary
Data. Considering the 4 more special symbols introduced similarly for
compound SMILES strings, we flattened the 4-tuples and thus defined a
protein SPS “alphabet" of 76 “letters".
The SPS representation overcomes drawbacks of Pfam-based baseline
representation: it provides higher resolution of sequence and structural
details for more challenging regression tasks, more distinguishability
among proteins in the same family, and more interpretability on which
protein segments (SSEs here) are responsible for predicted affinity. All
these are achieved with a much smaller alphabet of size 76 , which leads to
around 100-times more compact representation of a protein sequence than
the baseline. In addition, the SPS sequences are much shorter than amino-
acid sequences and prevents convergence issues when training RNN and
LSTM for sequences longer than 1,000 (Li et al., 2018).
2.3 RNN for unsupervised pre-training
We encode compound SMILES or protein SPS into representations,
first by unsupervised deep learning from abundant unlabeled data. We
used a recurrent neural network (RNN) model, seq2seq (Sutskever et al.,
2014), that has seen much success in natural language processing and
was recently applied to embedding compound SMILES strings into
fingerprints (Xu et al., 2017). A Seq2seq model is an auto-encoder that
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consists of two recurrent units known as the encoder and the decoder,
respectively (see the corresponding box in Fig. 1). The encoder maps an
input sequence (SMILES/SPS in our case) to a fixed-dimension vector
known as the thought vector. Then the decoder maps the thought vector to
the target sequence (again, SMILES/SPS here). We choose gated recurrent
unit (GRU) (Cho et al., 2014) as our default seq2seq model and treat
the thought vectors as the representations learned from the SMILES/SPS
inputs. The detailed GRU configuration and advanced variants (bucketing,
bidirectional GRU, and attention mechanism which provides a way to
“focus” for encoders) can be found in Sec. 1.4 of Supplementary Data.
Throughunsupervised pre-training, the learned representations capture
nonlinear joint dependencies among protein residues or compound atoms
that are far from each other in sequence. Such “long-term” dependencies
are very important to CPIs since corresponding residues or atoms can be
close in 3D structures and jointly contribute to intermolecular interactions.
2.4 Unified RNN-CNN for supervised learning
With compound and protein representations learned from the above
unsupervised learning, we solve the regression problem of compound-
protein affinity prediction using supervised learning. For either proteins
or compounds, we append a CNN after the RNN (encoders and attention
models only) that we just trained. The CNN model consists of a one-
dimensional (1D) convolution layer followed by a max-pooling layer. The
outputs of the two CNNs (one for proteins and the other for compounds)
are concatenated and fed into two more fully connected layers.
The entire RNN-CNN pipeline is trained from end to end (Wang et al.,
2016b), with the pre-trained RNNs serving as warm initializations, for
improved performance over two-step training. The pre-trained RNN
initializations prove to be very important for the non-convex training
process (Sutskever et al., 2013). In comparison to such a “unified” model,
we also include the “separate" RNN-CNN baseline for comparison, in
which we fixed the learned RNN part and train CNN on top of its outputs.
2.5 Attention mechanisms in unified RNN-CNN
Wehave also introduced three attention mechanisms to unified RNN-CNN
models. The goal is to both improve predictive performances and enable
model interpretability at the level of “letters" (SSEs in proteins and atoms
in compounds) and their pairs.
1) Separate attention. This default attention mechanism is applied to
the compound and the protein separately so the attention learned on each
side is non-specific to a compound-protein pair. However, it has the least
parameters among the three mechanisms.
2) Marginalized attention. To introduce pair-specific attentions, we
first use a pairwise “interaction” matrix for a pair and then marginalize it
based on maximization over rows or columns for separate compound or
protein attention models, which is motivated by Lu et al. (2016).
3) Joint attention. We have developed this novel attention model to
fully explain the pairwise interactions between components (compound
atoms andprotein SSEs). Specifically, weuse the samepairwise interaction
matrix but learn to represent the pairwise space and consider attentions on
pairwise interactions rather than “interfaces" on each side. Among the three
attention mechanisms, joint attention provides the best interpretability
albeit with the most parameters.
These attention models (for proteins, compounds, or their pairs)
are jointly trained with the RNN encoder and the CNN part. Learned
parameters of theirs include attention weights on all “letters” for a given
string (or those on all letter-pairs for a given string-pair). Compared to
that in unsupervised learning, each attention model here outputs a single
vector as the input to its corresponding subsequent 1D-CNN model.
More details on unified RNN-CNN and attention mechanisms can be
found in Sec. 1.5 of Supplementary Data.
3 Results and Discussion
3.1 Compound and protein representations
We compared the auto-encoding performances of our vanilla seq2seq
model and 4 variants: bucketing, bi-directional GRU (“fw+bw”), attention
mechanism, and attention mechanism with fw+bw, respectively, in Tables
S3 and S4 (Supplementary Data). We used the common assessment metric
in language models, perplexity, which is related to the entropy H of
modeled probability distribution P (Perp(P ) = 2H(P ) > 1). First,
the vanilla seq2seq model had lower test-set perplexity for compound
SMILES than protein SPS (7.07 versus 41.03), which echoes the fact that,
compared to protein SPS strings, compound SMILES strings are defined
in an alphabet of less letters (68 versus 76) and are of shorter lengths (100
versus 152), thus their RNNmodels are easier to learn. Second, bucketing,
the most ad-hoc option among all, did not improve the results much. Third,
whereas bi-directional GRUs lowered perplexity by about 2∼3.5 folds and
the default attentionmechanismdidmuchmore for compounds or proteins,
they together achieved the best performances (perplexity being 1.0002 for
compound SMILES and 1.001 for protein SPS).
Therefore, the last seq2seq variant, bidirectional GRUs with
attention mechanism, is regarded the most appropriate one for learning
compound/protein representations and adopted thereinafter.
3.2 Compound-protein affinity prediction
3.2.1 Comparing novel representations to baseline ones
To assess how useful the learned/encoded protein and compound
representations are for predicting compound-protein affinity, we compared
the novel and baseline representations in affinity regression using the
labeled datasets. The representations were compared under the same
shallow machine learning models — ridge regression, lasso regression
and random forest (RF).
Baseline representations Novel representations
Ridge Lasso RF Ridge Lasso RF
Training 1.16 (0.60) 1.16 (0.60) 0.76 (0.86) 1.23 (0.54) 1.22 (0.55) 0.63 (0.91)
Testing 1.16 (0.60) 1.16 (0.60) 0.91 (0.78) 1.23 (0.54) 1.22 (0.55) 0.91 (0.78)
ER 1.43 (0.30) 1.43 (0.30) 1.44 (0.37) 1.46 (0.18) 1.48 (0.18) 1.41 (0.26)
Ion Channel 1.32 (0.22) 1.34 (0.20) 1.30 (0.22) 1.26 (0.23) 1.32 (0.17) 1.24 (0.30)
GPCR 1.28 (0.22) 1.30 (0.22) 1.32 (0.28) 1.34 (0.20) 1.37 (0.17) 1.40 (0.25)
Tyrosine Kinase 1.16 (0.38) 1.16 (0.38) 1.18 (0.42) 1.50 (0.11) 1.51 (0.10) 1.58 (0.11)
Time (core hours) 3.5 7.4 1239.8 0.47 2.78 668.7
Memory (GB) 7.6 7.6 8.3 7.3 7.3 6.3
Table 1. Comparing the novel representations to the baseline based on RMSE
(and Pearson correlation coefficient r) of pIC50 shallow regression.
From Table 1 we found that our novel representations learned
from SMILES/SPS strings by seq2seq models outperform baseline
representations of k-hot encoding of molecular/Pfam features. For the best
performing random forest models, using 46% less training time and 24%
less memory, the novel representations achieved the same performance
over the default test set as the baseline ones and lowered root mean
squared errors (RMSE) for two of the four generalization sets whose
target protein classes (nuclear estrogen receptors / ER and ion channels)
are not included in the training set. Similar improvements were observed
on pKi, pKd, and pEC50 predictions in Tables S5–7 (Supplementary
Data), respectively. These results show that learning protein and compound
representations from even unlabeled datasets alone could improve their
context-relevance for various labels. We also note that, unlike Pfam-based
protein representations that exploit curated information only available
to some proteins and their homologs, our SPS representations do not
assume such information and can apply to uncharacterized proteins lacking
annotated homologs.
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3.2.2 Comparing shallow and deep models
Using the novel representations we next compared the performances of
affinity regression between the best shallow model (random forest) and
various deep models. For both separate and unified RNN-CNN models,
we tested results from a single model with (hyper)parameters optimized
over the training/validation set, averaging a “parameter ensemble” of 10
models derived in the last 10 epochs, and averaging a “parameter+NN”
ensemble of models with varying number of neurons in the fully connected
layers ((300,100), (400,200) and (600,300)) trained in the last 10 epochs.
The attention mechanism used here is the default, separate attention.
From Table 2 we noticed that unified RNN-CNN models outperform
both random forest and separate RNN-CNN models (the similar
performances between RF and separate RNN-CNN indicated a potential
to further improve RNN-CNN models with deeper models). By using a
relatively small amount of labeled data (which are usually expensive and
limited), protein and compound representations learned from abundant
unlabeled data can be tuned to be more task-specific. We also noticed that
averaging an ensemble of unified RNN-CNN models further improves
the performances especially for some generalization sets of ion channels
and GPCRs. As anticipated, averaging ensembles of models reduces the
variance originating fromnetwork architecture and parameter optimization
thus reduces expected generalization errors. Similar observations were
made for pKi predictions as well (Table S8 in Supplementary Data) even
when their hyper-parameters were not particularly optimized and simply
borrowed from pIC50 models. Impressively, unified RNN-CNN models
without very deep architecture could predict IC50 values with relative
errors below 100.7=5 fold (or 1.0 kcal/mol) for the test set and even around
101.3 = 20 fold (or 1.8 kcal/mol) on average for protein classes not seen
in the training set. Interestingly, GPCRs and ion channels had similar
RMSE but more different Pearson’s r, which is further described by the
distributions of predicted versus measured pIC50 values for various sets
(Fig. S5 in Supplementary Data).
3.2.3 Comparing attention mechanisms in prediction
To assess the predictive powers of the three attention mechanisms
introduced, we compared their pIC50 predictions in Table 3 using the same
dataset and the same unified RNN-CNN models as before. All attention
mechanisms had similar performances on the training and test sets.
However, as we anticipated, separate attention with the least parameters
edged joint attention in generalization (especially for receptor tyrosine
kinases). Meanwhile, joint attention had similar predictive performances
and much better interpretability, thus will be further examined in all
interpretability studies in case studies for selective drugs.
3.2.4 Deep transfer learning for new classes of protein targets
Using the generalization sets, weproceed to explain and address our unified
RNN-CNN models’ relatively worse performances for new classes of
protein targets without any training data. We chose to analyze separate
attention models with the best generalization results and first noticed
that proteins in various sets have different distributions in the SPS
alphabet (4-tuples). In particular, the test set, ion channels/GPCRs/tyrosine
kinases, and estrogen receptors are increasingly different from the
training set (measured by Jensen-Shannon distances in SPS letter or SPS
length distribution) (Fig. S3 in Supplementary Data), which correlated
with increasingly deteriorating performance relative to the training set
(measured by the relative difference in RMSE) with a Pearson correlation
coefficient of 0.68 (SPS letter distribution) or 0.96 (SPS length distribution)
(Fig. S4 in Supplementary Data).
To improve the performances for new classes of proteins, we compare
two strategies: re-training shallow models (random forest) from scratch
based on new training data alone and “transferring” original deep models
(unified parameter+NN ensemble with the default separate attention) to
fit new data (see details in Supplementary Data). The reason is that new
classes of targets often have few labeled data that might be adequate for
re-training class-specific shallow models from scratch but not for deep
models with much more parameters.
As shown in Fig. 2, deep transfer learning models increasingly
improved the predictive performance compared to the original deep
learning models, when increasing amount of labeled data for new protein
classes are made available. The improvement was significant even with
1% training coverage for each new protein class. Notably, deep transfer
learning models outperformed random forest models that were re-trained
specifically for each new protein class.
3.3 Predicting target selectivity of drugs
We went on to test how well our unified RNN-CNN models could predict
certain drugs’ target selectivity, using 3 sets of drug-target interactions
of increasing prediction difficulty. Our novel representations and models
successfully predicted target selectivity for 6 of 7 drugs whereas baseline
representations and shallow models (random forest) failed for most drugs.
3.3.1 Factor Xa versus Thrombin
Thrombin and factor X (Xa) are important proteins in the blood
coagulation cascade. Antithrombotics, inhibitors for such proteins, have
been developed to treat cardiovascular diseases. Due to thrombin’s other
significant roles in cellular functions and neurological processes, it is
desirable to develop inhibitors specifically for factor Xa. DX-9065a is
such a selective inhibitor (pKi value being 7.39 for Xa and <2.70 for
thrombin) (Brandstetter et al., 1996).
Baseline rep. + RF Novel rep. + RF Novel rep. + DL (sep. attn.) Novel rep. + DL (joint attn.)
Thrombin 6.36 6.71 5.68 4.77
Factor Xa 6.87 6.54 8.08 8.64
Table 4. Predicted pKi values and target specificity for compound DX-9065a
interacting with human factor Xa and thrombin.
Weused the learned pKi models in this study. Both proteins (thrombin
and factor Xa) were included in the Ki training set with 2,294 and
2,331 samples, respectively, but their interactions with the compound DX-
9065a were not.. Table 4 suggested that random forest correctly predicted
the target selectivity (albeit with smaller than 0.5-unit difference) using
baseline representations but failed to do so using novel representations.
In contrast, our models with separate and joint attention mechanisms
both correctly predicted the compound’s favoring Xa. Moreover, our
models predicted selectivity levels being 2.4 (separate attention) and 3.9
(joint attention) in pKi difference (∆pKi), where the joint attention
model produced predictions very close to the known selectivity margin
(∆pKi >4.7).
3.3.2 Cyclooxygenase (COX) protein family
COX protein family represents an important class of drug targets for
inflammatory diseases. These enzymes responsible for prostaglandin
biosynthesis include COX-1 and COX-2 in human, both of which can be
inhibited by nonsteroidal anti-inflammatory drugs (NSAIDs). We chose
three common NSAIDs known for human COX-1/2 selectivity: celecoxib
(pIC50 for COX-1: 4.09; COX-2: 5.17), ibuprofen (COX-1: 4.92, COX-2:
4.10) and rofecoxib (COX-1: <4; COX-2: 4.6) (Luo et al., 2017). This is
a very challenging case for selectivity prediction because selectivity levels
of all NSAIDs are close to or within 1 unit of pIC50 .
We used the learned pIC50 ensemble models in this study. COX-
1 and COX-2 both exist in our IC50 training set with 959 and 2,006
binding examples, respectively, including 2 of the 6 compound-protein
pairs (ibuprofen and celecoxib with COX-1 individually).
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Separate RNN-CNN Models Unified RNN-CNN Models
RF single parameter parameter+NN single parameter parameter+NN
ensemble ensemble ensemble ensemble
Training 0.63 (0.91) 0.68 (0.88) 0.67 (0.90) 0.68 (0.89) 0.47 (0.94) 0.45 (0.95) 0.44 (0.95)
Testing 0.91 (0.78) 0.94 (0.76) 0.92 (0.77) 0.90 (0.79) 0.78 (0.84) 0.77 (0.84) 0.73 (0.86)
Generalization – ER 1.41 (0.26) 1.45 (0.24) 1.44 (0.26) 1.43 (0.28) 1.53 (0.16) 1.52 (0.19) 1.46 (0.30)
Generalization – Ion Channel 1.24 (0.30) 1.36 (0.18) 1.33 (0.18) 1.29 (0.25) 1.34 (0.17) 1.33 (0.18) 1.30 (0.18)
Generalization – GPCR 1.40 (0.25) 1.44 (0.19) 1.41 (0.20) 1.37 (0.23) 1.40 (0.24) 1.40 (0.24) 1.36 (0.30)
Generalization – Tyrosine Kinase 1.58 (0.11) 1.66 (0.09) 1.62 (0.10) 1.54 (0.12) 1.24 (0.39) 1.25 (0.38) 1.23 (0.42)
Table 2. Under novel representations learned from seq2seq, comparing random forest and variants of separate RNN-CNN and unified RNN-CNNmodels based on
RMSE (and Pearson correlation coefficient r) for pIC50 prediction.
Separate attention Marginalized attention Joint attention
single parameter parameter+NN single parameter parameter+NN single parameter parameter+NN
ensemble ensemble ensemble ensemble ensemble ensemble
Training 0.47 (0.94) 0.45 (0.95) 0.44 (0.95) 0.50 (0.94) 0.47 (0.95) 0.42 (0.96) 0.48 (0.94) 0.44 (0.94) 0.40 (0.95)
Testing 0.78 (0.84) 0.77 (0.84) 0.73 (0.86) 0.81 (0.83) 0.79 (0.84) 0.73 (0.86) 0.84 (0.82) 0.80 (0.83) 0.73 (0.86)
Generalization – ER 1.53 (0.16) 1.52 (0.19) 1.46 (0.30) 1.69 (0.20) 1.67 (0.20) 1.53 (0.30) 1.78 (0.03) 1.68 (0.04) 1.37 (0.23)
Generalization – Ion Channel 1.34 (0.17) 1.33 (0.18) 1.30 (0.18) 1.63 (0.01) 1.64 (0.06) 1.41 (0.13) 1.54 (0.25) 1.53 (0.26) 1.42 (0.26)
Generalization – GPCR 1.40 (0.24) 1.40 (0.24) 1.36 (0.30) 1.59 (0.17) 1.57 (0.18) 1.42 (0.24) 1.53 (0.19) 1.53 (0.19) 1.38 (0.25)
Generalization – Tyrosine Kinase 1.24 (0.39) 1.25 (0.38) 1.23 (0.42) 1.69 (0.22) 1.62 (0.25) 1.50 (0.32) 2.22 (0.18) 2.17 (0.21) 2.04 (0.17)
Table 3. Under novel representations learned from seq2seq, comparing different attention mechanisms of unified RNN-CNNmodels based on RMSE (and Pearson
correlation coefficient r) for pIC50 prediction.
Nuclear Estrogen Receptor Ion Channel GPCR Receptor Tyrosine Kinase
Fig. 2. Comparing strategies to generalize predictions for four sets of new protein classes: original random forest (RF), original param.+NN ensemble of unified RNN-CNN models (DL
for deep learning with the default attention), and re-trained RF or transfer DL using incremental amounts of labeled data in each set.
Baseline rep. + RF Novel rep. + RF Novel rep. + DL (sep. attn.) Novel rep. + DL (joint attn.)
CEL IBU ROF CEL IBU ROF CEL IBU ROF CEL IBU ROF
COX-1 6.06 5.32 5.71 6.41 6.12 6.13 5.11 6.06 5.67 5.18 5.94 6.00
COX-2 6.06 5.32 5.71 6.57 6.19 6.21 7.60 5.96 6.51 7.46 5.62 6.03
Table 5. Predicted pIC50 values and target specificity for three NSAIDs (CEL:
celecoxib, IBU: ibuprofen and ROF: rofecoxib) interacting with human COX-1
and COX-2.
From Table 5, we noticed that, using the baseline representations,
random forest incorrectly predicted COX-1 and COX-2 to be equally
favorable targets for each drug. This is because the two proteins are
from the same family and their representations in Pfam domains are
indistinguishable. Using the novel representations, random forest correctly
predicted target selectivity for two of the three drugs (celecoxib and
rofecoxib), whereas our unified RNN-CNN models (both attention
mechanisms) did so for all three. Even though the selectivity levels of the
NSAIDs are very challenging to predict, our models were able to predict
all selectivities correctly with the caveat that few predicted differences
might not be statistically significant (for instance, the 0.03-unit difference
for rofecoxib using joint attention).
3.3.3 Protein-tyrosine phosphatase (PTP) family
Protein-tyrosine kinases and protein-tyrosine phosphatases (PTPs) are
controlling reversible tyrosine phosphorylation reactions which are critical
for regulating metabolic and mitogenic signal transduction processes.
Selective PTP inhibitors are sought for the treatment of various diseases
including cancer, autoimmunity, and diabetes. Compound 1 [2- (oxalyl-
amino)-benzoic acid or OBA] and its derivatives, compounds 2 and 3
(PubChem CID: 44359299 and 90765696) , are highly selective toward
PTP1B rather than other proteins in the family such as PTPRA, PTPRE,
PTPRC and SHP1 (Iversen et al., 2000). Specifically, the pKi values of
OBA, compound 2, and compound 3 against PTP1B are 4.63, 4.25, and
6.69, respectively; and their pKi differences to the closest PTP family
protein are 0.75, 0.7, and 2.47, respectively (Iversen et al., 2000).
We used the learned pKi ensemble models in this study. PTP1B,
PTPRA, PTPRC, PTPRE and SHP1 were included in the Ki training
set with 343, 33, 16, 6 and 5 samples respectively. These examples just
includedOBAbinding to all but SHP1 and compound 2 binding to PTPRC.
Results in Table 6 showed that random forest using baseline
representations cannot tell binding affinity differences within the PTP
family as the proteins’ Pfam descriptions are almost indistinguishable.
Using novel representations, random forest incorrectly predicted target
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Baseline rep. + RF Novel rep. + RF Novel rep. + DL (sep. attn.) Novel rep. + DL (joint attn.)
Protein Comp1 Comp2 Comp3 Comp1 Comp2 Comp3 Comp1 Comp2 Comp3 Comp1 Comp2 Comp3
PTP1B 4.15 3.87 5.17 6.70 6.55 6.71 3.76 3.84 3.92 2.84 4.10 4.04
PTPRA 4.15 3.87 5.17 6.29 6.59 6.27 2.73 2.90 3.44 2.39 2.62 2.12
PTPRC 4.15 3.87 5.17 6.86 6.73 6.87 3.37 3.25 3.19 3.36 3.49 2.97
PTPRE 4.15 3.87 5.17 6.79 6.68 6.81 3.83 3.75 3.85 2.75 2.93 2.61
SHP1 4.15 3.87 5.17 6.71 6.74 6.73 3.37 3.38 3.89 3.42 3.52 3.22
Table 6. Predicted pKi values and target specificity for three PTP1B-selective
compounds interacting with five proteins in the human PTP family.
selectivity for all 3 compounds, whereas unified RNN-CNN models with
both attention mechanisms correctly did so for all but one (compound
1 – OBA). We also noticed that, although the separate attention model
predicted likely insignificant selectivity levels for compounds 2 (∆pKi =
0.09) and 3 (∆pKi = 0.03), the joint attention model much improved the
prediction of selectivity margins (∆pKi = 0.58 and 0.82 for compounds
2 and 3, respectively) and their statistical significances.
3.4 Explaining target selectivity of drugs
After successfully predicting target selectivity for some drugs, we proceed
to explain using attention scores how our deep learning models did so and
what they reveal about those compound-protein interactions.
3.4.1 How do the compound-protein pairs interact?
Given that SPS and SMILES strings are interpretable and attention models
between RNN encoders and 1D convolution layers can report their focus,
we pinpoint SSEs in proteins and atoms in compounds with high attention
scores, which are potentially responsible for CPIs. To assess the idea, we
chose 3 compound-protein pairs that have 3D crystal complex structures
from the Protein Data Bank; and extracted residues in direct contacts with
ligands (their SSEs are regarded ground truth for binding site) for each
protein from ligplot diagrams provided through PDBsum (De Beer et al.,
2013). Based on joint attention scores αij ’s on pairs of protein SSE i and
compound atom j from the single unifiedRNN-CNNmodel, we picked the
top 10% (4) SSEs as predicted binding sites. Specifically, we first corrected
joint attention scores to be βij = αij −
(∑I
k=1 αkj
)
/I (∀i =
1, . . . , I, j = 1, . . . , J) to offset the contribution of any compound
atom j with promiscuous attentions over all protein SSEs. We then
calculated the attention score βi for protein SSE i by max-marginalization
(βi = maxj βij ). No negative βi was found in this case thus no further
treatment was adopted.
Number of SSEs Top 10% (4) SSEs predicted as binding site by joint attn.
Target–Drug Pair PDB ID total binding site # of TP Enrichment Best rank P value
Human COX2–rofecoxib 5KIR 40 6 1 1.68 4 1.1e-2
Human PTP1B–OBA 1C85 34 5 1 1.70 1 1.1e-10
Human factor Xa–DX9065 1FAX 31 4 3 5.81 2 2.2e-16
Table 7. Interpreting deep learning models: predicting binding sites based on
joint attentions.
Table 7 shows that, compared to randomly ranking the SSEs, our
approach can enrich binding site prediction by 1.7∼5.8 fold for the
three CPIs. Consistent with the case of target selectivity prediction, joint
attention performed better than separate attention did (Table S9). One-
sided paired t-tests (see details in Sec. 1.7 of Supplementary Data)
suggested that binding sites enjoyed higher attention scores than non-
binding sites in a statistically significant way. When the strict definition
of binding sites is relaxed to residues within 5Å of any heavy atom of the
ligand, results were further improved with all top 10% SSEs of factor Xa
being at the binding site (Table S10).
We delved into the predictions for factor Xa–DX-9065a interaction
in Fig. 3 (the other 2 are in Fig. S6 of Supplementary Data). Warmer
colors (higher attentions) are clearly focused near the ligand. The red loops
connected through a β strand (resi. 171–196) were correctly predicted to
be at the binding site with a high rank 2, thus a true positive (TP). The
SSE ranked first, a false positive, is its immediate neighbor in sequence
(resi. 162-170; red helix at the bottom) and is near the ligand. In fact,
as mentioned before, when the binding site definition is relaxed, all top
10% SSEs were at the binding site. Therefore, in the current unified
RNN-CNN model with attention mechanism, wrong attention could be
paid to sequence neighbors of ground truth; and additional information
(for instance, 2D contact maps or 3D structures of proteins, if available)
could be used as additional inputs to reduce false negatives.
We also max-marginalized βij over protein SSE i for βj – attention
score on atom j of the compound. Many high attention scores were
observed for compound atoms (Fig. S7), which is somewhat intuitive as
small-molecule compounds usually fit in protein pockets or grooves almost
entirely. The top-ranked atom happened to be a nitrogen atom forming a
hydrogen bond with an aspartate (Asp189) of factor Xa, although more
cases need to be studied more thoroughly for a conclusion.
Fig. 3. Interpreting deep learning models for factor Xa binding-site prediction based on
joint attention: 3D structure of factor Xa (colored cartoons including helices, sheets, and
coils) in complex with DX-9065a (black sticks) (PDB ID:1FAX) where protein SSEs are
color-coded by attention scores (βi) where warmer colors indicate higher attentions.
3.4.2 How are targets selectively interacted?
To predictively explain the selectivity origin of compounds, we designed
an approach to compare attention scores between pairs of CPIs and tested
it using factor Xa-selective DX-9065a with known specificity origin.
For selective compounds that interact with factor Xa over thrombin,
position 192 has been identified: it is a charge-neutral polar glutamine
(Gln192) in Xa but a negatively-charged glutamate (Glu192) in
thrombin (Huggins et al., 2012). DX-9065a exploited this difference
with a carboxylate group forming unfavorable electrostatic repulsion
with Glu192 in thrombin but favorable hydrogen bond with Gln192
in Xa. To compare DX-9065a interacting with the two proteins, we
performed amino-acid sequence alignment between the proteins and split
two sequences of mis-matched SSEs (count: 31 and 38) into those of
perfectly matched segments (count: 50 and 50). In the end, segment 42,
where SSE 26 of Xa and SSE 31 of thrombin align, is the ground truth
containing position 192 for target selectivity.
ForDX-9065a interacting with either factor Xa or thrombin, we ranked
the SSEs based on the attention scores from the unified RNN-CNN single
model and assigned each segment the same rank as its parent SSE. Due to
the different SSE counts between thrombin and factor Xa, we normalized
each rank for segment i by the corresponding SSE count for a rank ratio
ri. For each segment we then substracted from 1 the average of rank
ratios between factor Xa and thrombin interactions so that highly attended
segments in both proteins can be scored higher. Fig. 4 shows that the
ground-truth segment in red was ranked the 2nd among 50 segments albeit
with narrow margins over the next 3 segments.
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Fig. 4. Interpreting deep learningmodels for factor Xa specificity based on joint attentions.
Pairwise alignment of amino-acid sequences of factor Xa and thrombin decomposed both
sequences into 50 segments (labeled by indices). These segments are scored by one less the
average of the corrected attention rank ratios for the two compound-protein interactions.
The ground truth of specificity origin is in red.
4 Discussion
We lastly explore alternative representations of proteins and compounds
and discuss remaining challenges.
4.1 Protein representations using amino acid sequences
As shown earlier, our SPS representations integrate both sequence and
structure information of proteins and are much more compact compared
to the original amino acid sequences. That being said, there is a value
to consider a protein sequence representation with the resolution of
residues rather than SSEs: potentially higher-resolution precision and
interpretability. We started with unsupervised learning to encode the
protein sequence representation with seq2seq. More details are given in
Sec. 1.8 of Supplementary Data.
SPS rep. +attention+fw/bw seq. rep. +attention+fw/bw
Training error (Perplexity) 1.003 11.46
Testing error (Perplexity) 1.001 12.69
Time (h) 96 192
Table 8. Comparing the auto-encoding performances between amino acid and
SPS sequences using the best seq2seqmodel (bidirectional GRUswith attention
mechanism).
Compared to SPS representations, protein sequences are 10-times
longer and demanded 10-times more GRUs in seq2seq, which suggests
much more expensive training. Under the limited computational budget,
we trained the protein sequence seq2seq models using twice the time limit
on the SPS ones. The perplexity for the test set turned out to be over 12,
which is much worse than 1.001 in the SPS case (see Sec. 3.1) and deemed
inadequate for subsequent (semi-)supervised learning. Learning very long
sequences is challenging in general and calls for advanced architectures
of sequence models.
4.2 Unified RNN/GCNN-CNN for protein SPS strings and
compound graphs
We have chosen SMILES representations for compounds partly due to
recent advancements of sequence models especially in the field of natural
languageprocessing. Meanwhile, the descriptive power of SMILES strings
can have limitations. For instance, some syntactically invalid SMILES
strings can still correspond to valid chemical structures. Therefore, we
also explore chemical formulae (2D graphs) for compound representation.
We replaced RNN layers for compound sequences with graph CNN
(GCNN) in our unified model (separate attention) and kept the rest of the
architecture. This new architecture is named unified RNN/GCNN-CNN.
The GCNN part is adopting a very recently-developed method (Gao et al.,
2018) for compound-protein interactions. More details can be found in
Sec. 1.9 of Supplementary Data.
SMILES rep. Graph rep.
single parameter parameter+NN single parameter parameter+NN
ensemble ensemble ensemble ensemble
Training 0.47 (0.94) 0.45 (0.95) 0.44 (0.95) 0.55 (0.92) 0.54 (0.92) 0.55 (0.92)
Testing 0.78 (0.84) 0.77 (0.84) 0.73 (0.86) 1.50 (0.35) 1.50 (0.35) 1.34 (0.45)
Generalization – ER 1.53 (0.16) 1.52 (0.19) 1.46 (0.30) 1.68 (0.05) 1.67 (0.03) 1.67 (0.07)
Generalization – Ion Channel 1.34 (0.17) 1.33 (0.18) 1.30 (0.18) 1.43 (0.10) 1.41 (0.13) 1.35 (0.12)
Generalization – GPCR 1.40 (0.24) 1.40 (0.24) 1.36 (0.30) 1.63 (0.04) 1.61 (0.04) 1.49 (0.07)
Generalization – Tyrosine Kinase 1.24 (0.39) 1.25 (0.38) 1.23 (0.42) 1.74 (0.01) 1.71 (0.03) 1.70 (0.03)
Table 9. Comparing unified RNN-CNN (SMILES strings for compound
representation) and unified RNN/GCNN-CNN (graphs for compound
representation) based on RMSE (and Pearson’s correlation coefficient) for
pIC50 prediction.
Results in Table 9 indicate that the unified RNN/GCNN-CNN model
using compound graphs did not outperform the unified RNN-CNN model
using compound SMILES in RMSE and did a lot worse in Pearson’s
correlation coefficient. These results did not show the superiority of
SMILES versus graphs for compound representations per se. Rather, they
show that graph models need new architectures and further developments
to address the challenge. We note recent advancements in deep graph
models (Gilmer et al., 2017; Coley et al., 2017; Jin et al., 2018).
5 Conclusion
We have developed accurate and interpretable deep learning models for
predicting compound-protein affinity using only compound identities and
protein sequences. By taking advantage of massive unlabeled compound
and protein data besides labeled data in semi-supervised learning, we
have jointly trained unified RNN-CNN models for learning context- and
task-specific protein/compound representations and predicting compound-
protein affinity. These models outperform baseline machine-learning
models. And impressively, they achieve the relative error of IC50 within
5-fold for a comprehensive test set and even that within 10-fold for
generalization sets of protein classes unknown to the training set. Deeper
models would further improve the results. Moreover, for the generalization
sets, we have devised transfer-learning strategies to significantly improve
model performance using as few as 40 labeled samples.
Compared to conventional compound or protein representations using
molecular descriptors or Pfam domains, the encoded representations
learned from novel structurally-annotated SPS sequences and SMILES
strings improve both predictive power and training efficiency for various
machine learning models. Given the novel representations with better
interpretability, wehave included attentionmechanism in the unifiedRNN-
CNN models to quantify how much each part of proteins or compounds
are focused while the models are making the specific prediction for each
compound-protein pair.
When applied to case studies on drugs of known target-selectivity,
our models have successfully predicted target selectivity in all cases
whereas conventional compound/protein representations and machine
learning models have failed some. Furthermore, our analyses on attention
weights have shown promising results for predicting protein binding sites
as well as the origins of binding selectivity, thus calling for further method
development for better interpretability.
For protein representation, we have chosen SSE as the resolution
for interpretability due to the known sequence-size limitation of RNN
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models (Li et al., 2018). One can easily increase the resolution to residue-
level by simply feeding to ourmodels amino-acid sequences (preferentially
of length below 1,000) instead of SPS sequences, but needs to be aware of
the much increased computational burden and much worse convergence
when training RNNs. For compound representation, we have started with
1D SMILES strings and have also explored 2D graph representations
using graph CNN (GCNN). Although the resulting unified RNN/GCNN-
CNN model did not improve against unified RNN-CNN, graphs are more
descriptive for compounds and more developments in graph models are
needed to address remaining challenges.
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